These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29551350)

  • 1. Efficacy and safety of eberconazole 1% otic solution compared to clotrimazole 1% solution in patients with otomycosis.
    de la Paz Cota BR; Cepero Vega PP; Matus Navarrete JJ; Aguado Mulgado GE; Narváez Huerta JJ; Lamadrid Bautista E; Fiscal Chauteco E
    Am J Otolaryngol; 2018; 39(3):307-312. PubMed ID: 29551350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical azole treatments for otomycosis.
    Lee A; Tysome JR; Saeed SR
    Cochrane Database Syst Rev; 2021 May; 5(5):CD009289. PubMed ID: 34033120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections.
    del Palacio A; Ortiz FJ; Pérez A; Pazos C; Garau M; Font E
    Mycoses; 2001; 44(5):173-80. PubMed ID: 11486455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream.
    Repiso Montero T; López S; Rodríguez C; del Rio R; Badell A; Gratacós MR
    Int J Dermatol; 2006 May; 45(5):600-4. PubMed ID: 16700802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical clotrimazole in treatment of otomycosis.
    Khan F; Muhammad R; Khan MR; Rehman F; Iqbal J; Khan M; Ullah G
    J Ayub Med Coll Abbottabad; 2013; 25(1-2):78-80. PubMed ID: 25098061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of 3 per cent boric acid in 70 per cent alcohol versus 1 per cent clotrimazole solution in otomycosis patients: a randomised, controlled trial.
    Romsaithong S; Tomanakan K; Tangsawad W; Thanaviratananich S
    J Laryngol Otol; 2016 Sep; 130(9):811-5. PubMed ID: 27477534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial.
    Jimenez-Garcia L; Celis-Aguilar E; Díaz-Pavón G; Muñoz Estrada V; Castro-Urquizo Á; Hernández-Castillo N; Amaro-Flores E
    Braz J Otorhinolaryngol; 2020; 86(3):300-307. PubMed ID: 30826311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Povidone iodine soaked gelfoam for the treatment of recalcitrant otomycosis - Our experiences at a tertiary care teaching hospital of eastern India.
    Swain SK; Behera IC; Sahu MC; Das A
    J Mycol Med; 2018 Mar; 28(1):122-127. PubMed ID: 29223643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Clotrimazole 1% Solution Compared to Econazole Nitrate 1% + Triamcinolone Acetonide 0.1% Cream in Patient with Otomycosis.
    Mostafa MG; Ahmed S; Islam MR; Rahman MA; Khan L; Alam MM; Ahmed MB
    Mymensingh Med J; 2021 Jul; 30(3):638-643. PubMed ID: 34226449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment.
    Mofatteh MR; Naseripour Yazdi Z; Yousefi M; Namaei MH
    Braz J Otorhinolaryngol; 2018; 84(4):404-409. PubMed ID: 28549873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of Locacorten-Vioform and clotrimazole in otomycosis: A systematic review and one-way meta-analysis.
    Herasym K; Bonaparte JP; Kilty S
    Laryngoscope; 2016 Jun; 126(6):1411-9. PubMed ID: 26600419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review.
    Viswanatha B; Sumatha D; Vijayashree MS
    Ear Nose Throat J; 2012 Mar; 91(3):114-21. PubMed ID: 22430336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various topical antifungal agents in otomycosis, which is the best?
    Jwery AK
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S32-S34. PubMed ID: 35130214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eberconazole (Eberconazol, Eberconazole nitrate, WAS 2160).
    Drugs R D; 2002; 3(5):352-4. PubMed ID: 12455157
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of Clotrimazole in Prevention of Recurrent Otomycosis.
    Kiakojuri K; Rajabnia R; Mahdavi Omran S; Pournajaf A; Karami M; Taghizadeh Armaki M
    Biomed Res Int; 2019; 2019():5269535. PubMed ID: 31950041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of otomycosis with clotrimazole: results accordingly with the fungus isolated.
    Antunes J; Mendes N; Adónis C; Freire F
    Acta Otolaryngol; 2022; 142(9-12):664-667. PubMed ID: 36128634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.
    Nemati S; Hassanzadeh R; Khajeh Jahromi S; Delkhosh Nasrollah Abadi A
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):953-7. PubMed ID: 23595615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad spectrum antifungal agents in otomycosis.
    Bassiouny A; Kamel T; Moawad MK; Hindawy DS
    J Laryngol Otol; 1986 Aug; 100(8):867-73. PubMed ID: 3746101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of extemporaneously compounded 1% tetracaine to improve adherence with clotrimazole 1% topical solution in the treatment of ear infection: a case report.
    Kolling WM; McPherson TB; McJunkin JL
    Am J Otolaryngol; 2013; 34(6):757-8. PubMed ID: 23932769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eberconazole--pharmacological and clinical review.
    Moodahadu-Bangera LS; Martis J; Mittal R; Krishnankutty B; Kumar N; Bellary S; Varughese S; Rao PK
    Indian J Dermatol Venereol Leprol; 2012; 78(2):217-22. PubMed ID: 22421664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.